Sodium stibogluconate-associated acute interstitial nephritis in a patient treated for visceral leishmaniasis
The spectrum of side-effects of sodium stibogluconate is well described. Patients treated with sodium stibogluconate can develop varied manifestations of renal toxicity, ranging from renal cell casts, proteinuria, renal tubular acidosis and acute tubular necrosis, resulting in acute kidney injury (A...
Main Authors: | Sanjay Vikrant, Dalip Gupta, Satinder Singh Kaushal |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2015-01-01
|
Series: | Saudi Journal of Kidney Diseases and Transplantation |
Online Access: | http://www.sjkdt.org/article.asp?issn=1319-2442;year=2015;volume=26;issue=4;spage=757;epage=760;aulast=Vikrant |
Similar Items
-
Comparison of generic and proprietary sodium stibogluconate for the treatment of visceral leishmaniasis in Kenya
by: Moore Elinore, et al.
Published: (2001-01-01) -
High parasitological failure rate of visceral leishmaniasis to sodium stibogluconate among HIV co-infected adults in Ethiopia.
by: Ermias Diro, et al.
Published: (2014-05-01) -
Sodium stibogluconate (SSG) & paromomycin combination compared to SSG for visceral leishmaniasis in East Africa: a randomised controlled trial.
by: Ahmed Musa, et al.
Published: (2012-01-01) -
Efficacy and Safety of AmBisome in Combination with Sodium Stibogluconate or Miltefosine and Miltefosine Monotherapy for African Visceral Leishmaniasis: Phase II Randomized Trial.
by: Monique Wasunna, et al.
Published: (2016-09-01) -
Leishmaniasis of the lip diagnosed by lymph node aspiration and treated with a combination of oral ketaconazole and intralesional sodium stibogluconate
by: Biju Vasudevan, et al.
Published: (2011-01-01)